Cryopreservation of supernumerary high quality embryos predicts favorable outcomes for patients undergoing repeated cycles of in vitro fertilization

Fertility and Sterility

Volumn 89, Issue 2, 2008, Pages 368-374

  Wang, Jeff G ^a   Douglas, Nataki C ^a   Dicken, Cary ^a   Nakhuda, Gary S ^a   Guarnaccia, Michael M ^a   Sauer, Mark V ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

embryo cryopreservation; frozen embryo transfer; implantation; IVF; outcomes; pregnancy; repeated

Indexed keywords

ESTRADIOL; GONADORELIN; GONADOTROPIN; LEUPRORELIN;

ADULT; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; NIDATION; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL;

ADULT; ALGORITHMS; BLASTOCYST; COHORT STUDIES; CRYOPRESERVATION; EMBRYO DISPOSITION; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; OOCYTE RETRIEVAL; PREGNANCY; PREGNANCY RATE; PROGNOSIS; QUALITY CONTROL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 38949096419     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.03.031     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. 2004 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports (2006), Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA
2. Shapiro B.S., Richter K.S., Harris D.C., and Daneshmand S.T. Dramatic declines in implantation and pregnancy rates in patients who undergo repeated cycles of in vitro fertilization with blastocyst transfer after one or more failed attempts. Fertil Steril 76 (2001) 538-542
3. Silberstein T., Trimarchi J.R., Gonzalez L., Keefe D.L., and Blazar A.S. Pregnancy outcome in in vitro fertilization decreases to a plateau with repeated cycles. Fertil Steril 84 (2005) 1043-1045
4. Kolibianakis E.M., and Devroey P. No decrease occurs in the number of COCs retrieved with repeated IVF cycles. Hum Reprod 19 (2004) 1927-1928
5. Hoveyda F., Engmann L., Steele J., Lopez Bernal A., and Barlow D.H. Ovarian response in three consecutive in vitro fertilization cycles. Fertil Steril 77 (2002) 706-710
6. Doldi N., Persico P., De Santis L., Rabellotti E., Papaleo E., and Ferrari A. Consecutive cycles in in vitro fertilization-embryo transfer. Gynecol Endocrinol 20 (2005) 132-136
7. Kolibianakis E., Osmanagaoglu K., Camus M., Tournaye H., Van Steirteghem A., and Devroey P. Effect of repeated assisted reproductive technology cycles on ovarian response. Fertil Steril 77 (2002) 967-970
8. Guzick D.S., Wilkes C., and Jones Jr. H.W. Cumulative pregnancy rates for in vitro fertilization. Fertil Steril 46 (1986) 663-667
9. Meldrum D.R., Silverberg K.M., Bustillo M., and Stokes L. Success rate with repeated cycles of in vitro fertilization-embryo transfer. Fertil Steril 69 (1998) 1005-1009
10. De Vries M.J., De Sutter P., and Dhont M. Prognostic factors in patients continuing in vitro fertilization or intracytoplasmic sperm injection treatment and dropouts. Fertil Steril 72 (1999) 674-678
11. Padilla S.L., and Garcia J.E. Effect of maternal age and number of in vitro fertilization procedures on pregnancy outcome. Fertil Steril 52 (1989) 270-273
12. Haan G., Bernardus R.E., Hollanders J.M., Leerentveld R.A., Prak F.M., and Naaktgeboren N. Results of IVF from a prospective multicentre study. Hum Reprod 6 (1991) 805-810
13. Tan S.L., Royston P., Campbell S., Jacobs H.S., Betts J., Mason B., et al. Cumulative conception and livebirth rates after in-vitro fertilisation. Lancet 339 (1992) 1390-1394
14. Templeton A., Morris J.K., and Parslow W. Factors that affect outcome of in-vitro fertilisation treatment. Lancet 348 (1996) 1402-1406
15. FIVNAT (French In Vitro National). French National IVF Registry: analysis of 1986 to 1990 data. Fertil Steril 59 (1993) 587-595
16. Centers for Disease Control and Prevention. 1995 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports (1997), Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA
17. Al-Inany H.G., Abou-Setta A.M., and Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 3 (2006) CD001750
18. Albano C., Felberbaum R.E., Smitz J., Riethmuller-Winzen H., Engel J., Diedrich K., et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 15 (2000) 526-531
19. Bahceci M., Ulug U., Ben-Shlomo I., Erden H.F., and Akman M.A. Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study. J Reprod Med 50 (2005) 84-90
20. Borm G., and Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 15 (2000) 1490-1498
21. Check M.L., Check J.H., Choel J.K., Davies E., and Kiefer D. Effect of antagonists vs agonists on in vitro fertilization outcome. Clin Exp Obstet Gynecol 31 (2004) 257-259
22. Cheung L.P., Lam P.M., Lok I.H., Chiu T.T., Yeung S.Y., Tjer C.C., et al. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial. Hum Reprod 20 (2005) 616-621
23. Hohmann F.P., Macklon N.S., and Fauser B.C. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab 88 (2003) 166-173
24. Moon S.Y., Ku S.Y., Kim S.M., Jee B.C., Suh C.S., Choi Y.M., et al. Clinical efficacy of the gonadotropin-releasing hormone antagonist, ganirelix, in Korean women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer with recombinant follicle-stimulating hormone. J Obstet Gynaecol Res 31 (2005) 227-235
25. Marci R., Caserta D., Dolo V., Tatone C., Pavan A., and Moscarini M. GnRH antagonist in IVF poor-responder patients: results of a randomized trial. Reprod Biomed Online 11 (2005) 189-193
26. Fluker M., Grifo J., Leader A., Levy M., Meldrum D., Muasher S.J., et al. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 75 (2001) 38-45
27. Olivennes F., Belaisch-Allart J., Emperaire J.C., Dechaud H., Alvarez S., Moreau L., et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 73 (2000) 314-320
28. Rombauts L., Healy D., and Norman R.J. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum Reprod 21 (2006) 95-103
29. Zikopoulos K., Kaponis A., Adonakis G., Sotiriadis A., Kalantaridou S., Georgiou I., et al. A prospective randomized study comparing gonadotropin-releasing hormone agonists or gonadotropin-releasing hormone antagonists in couples with unexplained infertility and/or mild oligozoospermia. Fertil Steril 83 (2005) 1354-1362
30. The European Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 16 (2001) 644-651